NEW

Omjjara

Omjjara ATC Classification

Manufacturer:

Patheon

Distributor:

Zuellig

Marketer:

GlaxoSmithKline

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

ATC Classification

L01EJ04 - momelotinib ; Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.

Exclusive offer for doctors

Register for a MIMS account and receive free medical publications worth $768 a year.

Already a member? Sign in